Additional strategies to target Hexokinase 1 will have to follow the approach outlined here of targeting a cancer-specific pathway that drives Hexokinase 1 protein levels or activity rather than targeting Hexokinase 1 directly. The gene discussed is HK1; the disease is cancer.